10-Q Filing

MOLINA HEALTHCARE, INC. CIK: 1179929 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001179929-22-000172`
Period End Date	20220930
Filing Date	20221027
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	moh-20220930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 80 Cash Flow Statement 64 Stockholders Equity 39 Comprehensive Income 27

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.24B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	58.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.44B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.36B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	58.00M	shares	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$3.20B	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$3.64B	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Receivables	`ReceivablesNetCurrent`	$2.18B	USD	Point-in-time
Receivables	`ReceivablesNetCurrent`	$2.22B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$247.00M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$391.00M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$10.06B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$10.49B	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$396.00M	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$412.00M	USD	Point-in-time
Goodwill, and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$1.26B	USD	Point-in-time
Goodwill, and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$1.25B	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$212.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$242.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$198.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$106.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$179.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$186.00M	USD	Point-in-time
Total assets	`Assets`	$12.21B	USD	Point-in-time
Total assets	`Assets`	$12.79B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$3.19B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$3.62B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$3.36B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$2.70B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$2.14B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$2.47B	USD	Point-in-time
Accounts payable, accrued liabilities and other	`AccountsPayableAndAccruedLiabilitiesCurrent`	$842.00M	USD	Point-in-time
Accounts payable, accrued liabilities and other	`AccountsPayableAndAccruedLiabilitiesCurrent`	$818.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$663.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$370.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.05B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.24B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.17B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.17B	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$217.00M	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$219.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$140.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$118.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.75B	USD	Point-in-time
Total liabilities	`Liabilities`	$9.58B	USD	Point-in-time
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 58 million shares at September 30, 2022 and December 31, 2021	`CommonStockValueOutstanding`	-	USD	Point-in-time
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 58 million shares at September 30, 2022 and December 31, 2021	`CommonStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$236.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$289.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-185.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.40B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.94B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.79B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.37B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.83B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.63B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$3.04B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.10B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.52B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.16B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$12.79B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$12.21B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Premium revenue	`PremiumsEarnedNet`	$7.64B	USD	1 Quarter
Premium revenue	`PremiumsEarnedNet`	$19.69B	USD	3 Qtrs
Premium revenue	`PremiumsEarnedNet`	$6.80B	USD	1 Quarter
Premium revenue	`PremiumsEarnedNet`	$22.97B	USD	3 Qtrs
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$576.00M	USD	3 Qtrs
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$646.00M	USD	3 Qtrs
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$223.00M	USD	1 Quarter
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$204.00M	USD	1 Quarter
Investment income	`NetInvestmentIncome`	$82.00M	USD	3 Qtrs
Investment income	`NetInvestmentIncome`	$20.00M	USD	1 Quarter
Investment income	`NetInvestmentIncome`	$49.00M	USD	1 Quarter
Investment income	`NetInvestmentIncome`	$39.00M	USD	3 Qtrs
Other revenue	`InterestAndDividendIncomeOperating`	$16.00M	USD	1 Quarter
Other revenue	`InterestAndDividendIncomeOperating`	$19.00M	USD	1 Quarter
Other revenue	`InterestAndDividendIncomeOperating`	$58.00M	USD	3 Qtrs
Other revenue	`InterestAndDividendIncomeOperating`	$57.00M	USD	3 Qtrs
Total revenue	`Revenues`	$23.75B	USD	3 Qtrs
Total revenue	`Revenues`	$20.36B	USD	3 Qtrs
Total revenue	`Revenues`	$7.04B	USD	1 Quarter
Total revenue	`Revenues`	$7.93B	USD	1 Quarter
Medical care costs	`CostOfGoodsAndServicesSold`	$20.18B	USD	3 Qtrs
Medical care costs	`CostOfGoodsAndServicesSold`	$6.05B	USD	1 Quarter
Medical care costs	`CostOfGoodsAndServicesSold`	$17.34B	USD	3 Qtrs
Medical care costs	`CostOfGoodsAndServicesSold`	$6.75B	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$560.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$532.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.49B	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.68B	USD	3 Qtrs
Premium tax expenses	`PremiumTaxExpenses`	$576.00M	USD	3 Qtrs
Premium tax expenses	`PremiumTaxExpenses`	$223.00M	USD	1 Quarter
Premium tax expenses	`PremiumTaxExpenses`	$204.00M	USD	1 Quarter
Premium tax expenses	`PremiumTaxExpenses`	$646.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$45.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$129.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$96.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$32.00M	USD	1 Quarter
Other	`OtherCostAndExpenseOperating`	$30.00M	USD	3 Qtrs
Other	`OtherCostAndExpenseOperating`	$2.00M	USD	1 Quarter
Other	`OtherCostAndExpenseOperating`	$43.00M	USD	3 Qtrs
Other	`OtherCostAndExpenseOperating`	$16.00M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$22.68B	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$6.82B	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$19.53B	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$7.59B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$829.00M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$335.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$221.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$1.07B	USD	3 Qtrs
Interest expense	`InterestExpense`	$90.00M	USD	3 Qtrs
Interest expense	`InterestExpense`	$30.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$83.00M	USD	3 Qtrs
Interest expense	`InterestExpense`	$28.00M	USD	1 Quarter
Total other expenses, net	`NonoperatingIncomeExpense`	$-30.00M	USD	1 Quarter
Total other expenses, net	`NonoperatingIncomeExpense`	$-83.00M	USD	3 Qtrs
Total other expenses, net	`NonoperatingIncomeExpense`	$-90.00M	USD	3 Qtrs
Total other expenses, net	`NonoperatingIncomeExpense`	$-28.00M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$739.00M	USD	3 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$191.00M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$307.00M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$985.00M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$249.00M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$77.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$183.00M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$48.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$230.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$228.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$556.00M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$185.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$248.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$258.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$143.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$736.00M	USD	3 Qtrs
Net income per share - Basic (in dollars per share)	`EarningsPerShareBasic`	$12.74	USD	3 Qtrs
Net income per share - Basic (in dollars per share)	`EarningsPerShareBasic`	$2.49	USD	1 Quarter
Net income per share - Basic (in dollars per share)	`EarningsPerShareBasic`	$4.00	USD	1 Quarter
Net income per share - Basic (in dollars per share)	`EarningsPerShareBasic`	$9.63	USD	3 Qtrs
Net income per share - Diluted (in dollars per share)	`EarningsPerShareDiluted`	$9.51	USD	3 Qtrs
Net income per share - Diluted (in dollars per share)	`EarningsPerShareDiluted`	$12.58	USD	3 Qtrs
Net income per share - Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.95	USD	1 Quarter
Net income per share - Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.46	USD	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$143.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$258.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$248.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$736.00M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$185.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$556.00M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$228.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$230.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$129.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$96.00M	USD	3 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$8.00M	USD	3 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$35.00M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$49.00M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$80.00M	USD	3 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$9.00M	USD	3 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$-3.00M	USD	3 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$15.00M	USD	3 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$247.00M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$43.00M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$110.00M	USD	3 Qtrs
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$522.00M	USD	3 Qtrs
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$251.00M	USD	3 Qtrs
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$810.00M	USD	3 Qtrs
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$-360.00M	USD	3 Qtrs
Accounts payable, accrued liabilities and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$129.00M	USD	3 Qtrs
Accounts payable, accrued liabilities and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-40.00M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$293.00M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-374.00M	USD	3 Qtrs
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$59.00M	USD	3 Qtrs
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$23.00M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$985.00M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.52B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$2.02B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$1.76B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$965.00M	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.08B	USD	3 Qtrs
Net cash paid in business combinations	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$134.00M	USD	3 Qtrs
Net cash paid in business combinations	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$56.00M	USD	3 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$81.00M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$41.00M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-3.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-938.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.11B	USD	3 Qtrs
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	$200.00M	USD	3 Qtrs
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	$128.00M	USD	3 Qtrs
Common stock withheld to settle employee tax obligations	`CommonStockWithheldToSettleEmployeeTaxObligations`	$52.00M	USD	3 Qtrs
Common stock withheld to settle employee tax obligations	`CommonStockWithheldToSettleEmployeeTaxObligations`	$53.00M	USD	3 Qtrs
Contingent consideration liabilities settled	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$20.00M	USD	3 Qtrs
Contingent consideration liabilities settled	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$20.00M	USD	3 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$15.00M	USD	3 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-4.00M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-258.00M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-204.00M	USD	3 Qtrs
Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$212.00M	USD	3 Qtrs
Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-211.00M	USD	3 Qtrs
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.43B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.22B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.51B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.51B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.22B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.43B	USD	Point-in-time

Stockholders Equity 39 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$2.63B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$3.04B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$2.52B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$2.83B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$2.37B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$2.79B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$2.10B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$2.16B	USD	Point-in-time
Net income	`NetIncomeLoss`	$230.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$228.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$556.00M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$185.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$248.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$258.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$143.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$736.00M	USD	3 Qtrs
Common stock purchases	`StockRepurchasedDuringPeriodValue`	$122.00M	USD	1 Quarter
Common stock purchases	`StockRepurchasedDuringPeriodValue`	$200.00M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-57.00M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-47.00M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-20.00M	USD	3 Qtrs
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-180.00M	USD	3 Qtrs
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-76.00M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-9.00M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-11.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$-27.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$-18.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$14.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$35.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$38.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$21.00M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$2.10B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$2.63B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$3.04B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$2.52B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$2.83B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$2.37B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$2.79B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$2.16B	USD	Point-in-time

Comprehensive Income 27 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$143.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$258.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$248.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$736.00M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$185.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$556.00M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$228.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$230.00M	USD	1 Quarter
Unrealized investment loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-27.00M	USD	3 Qtrs
Unrealized investment loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-13.00M	USD	1 Quarter
Unrealized investment loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-75.00M	USD	1 Quarter
Unrealized investment loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-237.00M	USD	3 Qtrs
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-4.00M	USD	1 Quarter
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-57.00M	USD	3 Qtrs
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-7.00M	USD	3 Qtrs
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-18.00M	USD	1 Quarter
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-11.00M	USD	1 Quarter
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-180.00M	USD	3 Qtrs
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-76.00M	USD	1 Quarter
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-9.00M	USD	1 Quarter
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-20.00M	USD	3 Qtrs
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-57.00M	USD	1 Quarter
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-47.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$536.00M	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$556.00M	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$173.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$134.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.